Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City.
Saxena A, Engel AJ, Banbury B, Hasan G, Fraser N, Zaminski D, Masson M, Haberman RH, Scher JU, Ho G, Law J, Rackoff P, Tseng CE, Belmont HM, Clancy RM, Buyon JP, Izmirly PM.
Saxena A, et al.
Lancet Rheumatol. 2022 Sep;4(9):e582-e585. doi: 10.1016/S2665-9913(22)00190-4. Epub 2022 Jul 12.
Lancet Rheumatol. 2022.
PMID: 35856060
Free PMC article.
No abstract available.